| Sector | Prev | Curr ▼ | Delta |
|---|---|---|---|
| Pharmaceuticals & Biotechnology | 73.0% | 74.5% | ▲ +1.5% |
| Healthcare Services | 24.3% | 23.7% | ▼ -0.6% |
| Healthcare Equipment & Supplies | 1.2% | 1.0% | ▼ -0.2% |
| Insurance | 0.3% | 0.2% | ● 0.0% |
| Sector | Prev | Curr ▼ | Delta |
|---|---|---|---|
| Pharmaceuticals & Biotechnology | 74.5% | 71.5% | ▼ -2.9% |
| Healthcare Services | 23.7% | 26.1% | ▲ +2.5% |
| Healthcare Equipment & Supplies | 1.0% | 1.1% | ▲ +0.1% |
| Insurance | 0.2% | 0.2% | ● +0.0% |
Comparing Mar 2026 → Apr 2026
| # | Stock | Sector | Weight (Apr 2026) |
|---|---|---|---|
| 1 | Dr. Lal Path Labs Limited ₹6.02 Cr |
Healthcare Services | 1.21% |
| 2 | Metropolis Healthcare Limited ₹3.78 Cr |
Healthcare Services | 0.76% |
| # | Stock | Sector | Last Weight (Mar 2026) |
|---|---|---|---|
| 1 | Dr. Reddy's Laboratories Limited ₹6.27 Cr |
Pharmaceuticals & Biotechnology | 1.42% |
| # | Stock | Sector | Mar 2026 | Apr 2026 | Change |
|---|---|---|---|---|---|
| 1 | Mankind Pharma Limited ₹13.48 Cr |
Pharmaceuticals & Biotechnology | 1.72% | 2.72% | +1.00% |
| 2 | Cipla Limited ₹20.95 Cr |
Pharmaceuticals & Biotechnology | 3.32% | 4.22% | +0.90% |
| 3 | Krishna Institute Of Medical Sciences Limited ₹17.67 Cr |
Healthcare Services | 2.81% | 3.56% | +0.75% |
| 4 | Park Medi World Limited ₹18.79 Cr |
Healthcare Services | 3.48% | 3.79% | +0.31% |
| 5 | Yatharth Hospital & Trauma Care Serv Ltd ₹7.38 Cr |
Healthcare Services | 1.26% | 1.49% | +0.23% |
| 6 | Rubicon Research Limited ₹9.70 Cr |
Pharmaceuticals & Biotechnology | 1.75% | 1.96% | +0.21% |
| 7 | Fortis Healthcare Limited ₹24.00 Cr |
Healthcare Services | 4.67% | 4.84% | +0.17% |
| 8 | Orchid Pharma Limited ₹6.26 Cr |
Pharmaceuticals & Biotechnology | 1.09% | 1.26% | +0.17% |
| 9 | Sun Pharmaceutical Industries Limited ₹69.62 Cr |
Pharmaceuticals & Biotechnology | 13.91% | 14.04% | +0.13% |
| 10 | EQ - LAXMI DENTAL LIMITED ₹5.67 Cr |
Healthcare Equipment & Supplies | 1.02% | 1.14% | +0.12% |
| # | Stock | Sector | Mar 2026 | Apr 2026 | Change |
|---|---|---|---|---|---|
| 1 | Lupin Limited ₹14.98 Cr |
Pharmaceuticals & Biotechnology | 4.19% | 3.02% | -1.17% |
| 2 | JB Chemicals & Pharmaceuticals Limited ₹32.90 Cr |
Pharmaceuticals & Biotechnology | 7.51% | 6.63% | -0.88% |
| 3 | Max Healthcare Institute Limited ₹31.28 Cr |
Healthcare Services | 6.96% | 6.31% | -0.65% |
| 4 | Acutaas Chemicals Ltd ₹22.83 Cr |
Pharmaceuticals & Biotechnology | 5.09% | 4.60% | -0.49% |
| 5 | Gland Pharma Limited ₹8.75 Cr |
Pharmaceuticals & Biotechnology | 2.11% | 1.76% | -0.35% |
| 6 | Alkem Laboratories Limited ₹10.26 Cr |
Pharmaceuticals & Biotechnology | 2.40% | 2.07% | -0.33% |
| 7 | Apollo Hospitals Enterprise Limited ₹15.27 Cr |
Healthcare Services | 3.35% | 3.08% | -0.27% |
| 8 | Ajanta Pharma Limited ₹11.86 Cr |
Pharmaceuticals & Biotechnology | 2.66% | 2.39% | -0.27% |
| 9 | Aurobindo Pharma Limited ₹13.09 Cr |
Pharmaceuticals & Biotechnology | 2.80% | 2.64% | -0.16% |
| 10 | Divi's Laboratories Limited ₹29.26 Cr |
Pharmaceuticals & Biotechnology | 6.05% | 5.90% | -0.15% |
33 stocks — Apr 2026
| # | Stock | Sector | Cap | Weight & Value |
|---|---|---|---|---|
| 1 |
₹69.62 Cr |
Pharmaceuticals & Biotechnology |
14.04%
|
|
| 2 |
₹32.90 Cr |
Pharmaceuticals & Biotechnology |
6.63%
|
|
| 3 |
₹31.28 Cr |
Healthcare Services |
6.31%
|
|
| 4 |
₹29.26 Cr |
Pharmaceuticals & Biotechnology |
5.90%
|
|
| 5 |
₹24.00 Cr |
Healthcare Services |
4.84%
|
|
| 6 |
₹22.83 Cr |
Pharmaceuticals & Biotechnology |
4.60%
|
|
| 7 |
₹20.95 Cr |
Pharmaceuticals & Biotechnology |
4.22%
|
|
| 8 |
₹18.79 Cr |
Healthcare Services |
3.79%
|
|
| 9 |
₹17.67 Cr |
Healthcare Services |
3.56%
|
|
| 10 |
₹15.27 Cr |
Healthcare Services |
3.08%
|
Disclaimer: Data sourced from individual AMC monthly portfolio disclosures, as mandated by SEBI/AMFI. While we strive for accuracy, errors in parsing or presentation may occasionally occur. This is not investment advice. Please consult a SEBI-registered investment adviser before making any investment decisions.
Found a discrepancy or have feedback? Contact Us — we read every message personally.